These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12100790)

  • 1. Controlled multicenter study on the effect of computer assistance in intensive insulin therapy of type 1 diabetics.
    Schrezenmeir J; Dirting K; Papazov P
    Comput Methods Programs Biomed; 2002 Aug; 69(2):97-114. PubMed ID: 12100790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved blood glucose variability, HbA1c insuman Infusat and less insulin requirement in IDDM patients using insulin lispro in CSII. The Swedish Multicenter Lispro Insulin Study.
    Johansson UB; Adamson UC; Lins PE; Wredling RA
    Diabetes Metab; 2000 May; 26(3):192-6. PubMed ID: 10880892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled study on the use of hand-held insulin dosage computers enabling conversion to and optimizing of meal-related insulin therapy regimens.
    Schrezenmeir J; Achterberg H; Bergeler J; Küstner E; Stümer W; Hutten H; Beyer J
    Life Support Syst; 1985; 3 Suppl 1():561-7. PubMed ID: 3916620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of information technology for the management of intensive insulin therapy in type 1 diabetes mellitus.
    Boukhors Y; Rabasa-Lhoret R; Langelier H; Soultan M; Lacroix A; Chiasson JL
    Diabetes Metab; 2003 Dec; 29(6):619-27. PubMed ID: 14707892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps.
    Melki V; Renard E; Lassmann-Vague V; Boivin S; Guerci B; Hanaire-Broutin H; Bringer J; Belicar P; Jeandidier N; Meyer L; Blin P; Augendre-Ferrante B; Tauber JP
    Diabetes Care; 1998 Jun; 21(6):977-82. PubMed ID: 9614617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additional lunchtime basal insulin during insulin lispro intensive therapy in a randomized, multicenter, crossover study in adults : a real-life design.
    Stades AM; Hoekstra JB; van den Tweel I; Erkelens DW; Holleman F;
    Diabetes Care; 2002 Apr; 25(4):712-7. PubMed ID: 11919130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical application of two computerized diabetes management systems: comparison with the log-book method.
    Ryff-de Lèche A; Engler H; Nützi E; Berger M; Berger W
    Diabetes Res; 1992 Mar; 19(3):97-105. PubMed ID: 1344707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control.
    DeVries JH; Snoek FJ; Kostense PJ; Masurel N; Heine RJ;
    Diabetes Care; 2002 Nov; 25(11):2074-80. PubMed ID: 12401759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes.
    Kinsley BT; Weinger K; Bajaj M; Levy CJ; Simonson DC; Quigley M; Cox DJ; Jacobson AM
    Diabetes Care; 1999 Jul; 22(7):1022-8. PubMed ID: 10388961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
    Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
    Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin.
    Porcellati F; Rossetti P; Pampanelli S; Fanelli CG; Torlone E; Scionti L; Perriello G; Bolli GB
    Diabet Med; 2004 Nov; 21(11):1213-20. PubMed ID: 15498088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group.
    Holleman F; Schmitt H; Rottiers R; Rees A; Symanowski S; Anderson JH
    Diabetes Care; 1997 Dec; 20(12):1827-32. PubMed ID: 9405901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insulin therapy of Type I diabetes].
    Berger W
    Ther Umsch; 1996 Dec; 53(12):902-13. PubMed ID: 9036568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy.
    Fulcher GR; Gilbert RE; Yue DK
    Intern Med J; 2005 Sep; 35(9):536-42. PubMed ID: 16105155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.
    Roach P; Bai S; Charbonnel B; Consoli A; Taboga C; Tiengo A; Bolli G;
    Clin Ther; 2004 Apr; 26(4):502-10. PubMed ID: 15189747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents.
    Holcombe JH; Zalani S; Arora VK; Mast CJ;
    Clin Ther; 2002 Apr; 24(4):629-38. PubMed ID: 12017407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial insulin lispro. A new therapeutic option for type 1 diabetic patients.
    Schernthaner G; Wein W; Sandholzer K; Equiluz-Bruck S; Bates PC; Birkett MA
    Diabetes Care; 1998 Apr; 21(4):570-3. PubMed ID: 9571344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired absorption and omission of insulin: a novel method of detection using the diabetes advisory system computer model.
    Turner BC; Hejlesen OK; Kerr D; Cavan DA
    Diabetes Technol Ther; 2001; 3(1):99-109. PubMed ID: 11469714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computerization of the Yale insulin infusion protocol and potential insights into causes of hypoglycemia with intravenous insulin.
    Marvin MR; Inzucchi SE; Besterman BJ
    Diabetes Technol Ther; 2013 Mar; 15(3):246-52. PubMed ID: 23289409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.